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Helix-Loop-Helix Proteins Regulate
Pre-TCR and TCR Signaling through
Modulation of Rel/NF-B Activities
development of  T cells to the DP stage is driven by
signals from the pre-T cell receptor (pre-TCR) along with
signals from cytokine receptors (Haks et al., 1999). The
pre-T cell receptor signals through the Src family of
protein tyrosine kinases (PTK) including lck and Fyn.
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They phosphorylate ITAM motifs in the pre-TCR, thus825 NE 13th Street
providing docking sites for cytosolic PTK including SykOklahoma City, Oklahoma 73104
and ZAP70. Through subsequent phosphorylation of the2 Section of Immunobiology
adaptor molecules, SPL-76 and LAT, these kinases trig-Department of Molecular Biophysics
ger the ras-MAP kinase (MAPK) and protein kinase Cand Biochemistry
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the  locus (Kruisbeek et al., 2000). However, major
questions related to how developing thymocytes inter-
pret signals delivered via pre-TCR and TCR are not en-Summary
tirely understood.
Knockout mice lacking components of the pre-TCRE2A and HEB are basic helix-loop-helix transcription
signaling pathway, such as pT, TCR, CD3, CD3, lckfactors essential for T cell development. Complete in-
and Fyn, ZAP70 and syk, SLP76, or LAT, display a sharedhibition of their activities through transgenic overex-
phenotype—namely, a developmental block at the DN-pression of their inhibitors Id1 and Tal1 leads to a
III stage (Aifantis et al., 1997; Cheng et al., 1997; Clem-dramatic loss of thymocytes. Here, we suggest that
ents et al., 1998; Fehling et al., 1995; Groves et al., 1996;bHLH proteins play important roles in establishing
Haks et al., 1998; Malissen et al., 1995; Pivniouk et al.,thresholds for pre-TCR and TCR signaling. Inhibition
1998; Sugawara et al., 1998; van Oers et al., 1996; Zhangof their function allows double-negative cells to differ-
et al., 1999). These results suggest that the DN-III toentiate without a functional pre-TCR, while anti-CD3
DN-IV transition represents a critical step for pre-TCR-stimulation downregulates bHLH activities. We also
mediated development of T cells. The recombination-find that the transcription factor NF-B becomes acti-
activating genes, RAG1 and RAG2, are essential for thevated in transgenic thymocytes. Further activation of
rearrangement of TCR and  genes, and therefore dis-NF-B exacerbates the loss of thymocytes, whereas
ruption of RAG1 or RAG2 also leads to a complete blockinhibition of NF-B leads to the rescue of double-posi-
of thymocyte differentiation at the CD44CD25 DN-tive thymocytes. Therefore, we propose that E2A and
III stage (Mombaerts et al., 1992; Shinkai et al., 1992).HEB negatively regulate pre-TCR and TCR signaling
Because the absence of RAG proteins only abolishesand their removal causes hyperactivation and apopto-
rearrangement of the TCR genes, RAG-deficient micesis of thymocytes.
are useful models for testing the role of different factors
that influence the pre-TCR signaling pathway. For exam-Introduction
ple, it has been shown that the introduction of activated
lck, Ras, or Raf, as well as antibodies against CD3, canStages of T cell development in the thymus are charac-
overcome the developmental block at the DN-III stage
terized by the expression of cell surface molecules such
in RAG-deficient mice (Aifantis et al., 1997; Gartner et
as the CD4 and CD8 coreceptors. The most immature
al., 1999; Iritani et al., 1999; Shinkai and Alt, 1994; Swat
thymocytes express neither CD4 nor CD8 (double-nega- et al., 1996).
tive stage, DN), and further development leads to the The nuclear effectors of the pre-TCR signaling path-
expression of both CD4 and CD8 (double-positive stage, way include transcription factors activated by the Ras-
DP). Finally, the DP cells mature into fully differenti- MAPK and PKC pathways. Activation of MAP kinases
ated cells that express either CD4 or CD8 (CD4 or CD8 (Erks, JNKs, and p38) leads to their translocation into
single-positive cells, SP) and exit the thymus (Haks et the nucleus, where they phosphorylate and activate
al., 1999; von Boehmer et al., 1999). In addition, the transcription factors of the Fos, Jun, Est, and Egr fami-
expression of two other cell surface proteins, CD44 and lies (Jacobs, 2000). The AP-1 DNA binding complex,
CD25, has been used to further subdivide DN cells into which consists of Fos and Jun proteins, is known to be
four additional developmental stages: CD44CD25 involved in cell proliferation and transformation, but its
(DN-I), CD44CD25 (DN-II), CD44CD25 (DN-III), and role in thymocyte development is not clear. Overexpres-
CD44CD25 (DN-IV) (Godfrey et al., 1993; Hoffman et sion of the Egr1 transcription factor, however, leads to
al., 1996). Successful rearrangement of the  chain of the differentiation of RAG2-deficient cells to the imma-
the T cell receptor (TCR) gene at the DN-III stage leads ture CD8 single-positive stage, which lies between the
to the assembly and expression of a pre-TCR that con- DN and DP stages (Miyazaki, 1997). Pre-TCR signaling
tains the rearranged  chain and the pTprotein. Further also leads to the activation of transcription factors that
belong to the Rel/NF-B family (Aifantis et al., 2001; Sen
et al., 1995; Voll et al., 2000; Zuniga-Pflucker et al., 1993).3 Correspondence: sunx@omrf.ouhsc.edu
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Figure 1. Dose-Dependent Inhibition of T Cell Development by Id1 and Tal1 Transgenes
(A) Schematic diagrams of transgenic constructs expressing Id1, Tal1-p22, and E47 cDNAs. Expression of the transgenes was driven by the
proximal promoter of the lck gene as represented by a dark shaded box. The human growth hormone gene provided 3 untranslated sequences
as shown by the light shaded box. Various cDNA inserts are depicted as open boxes with bHLH domains marked as filled boxes.
(B) CD4 and CD8 staining of total thymocytes from mice with the indicated genotypes. The Id1 homozygous and heterozygous transgenic
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Recently, the importance of NF-B in pre-TCR signaling tion partners nor dimerize with each other (Sun et al.,
1991). We have now generated transgenic mice in whichwas demonstrated by using a transgene expressing a
constitutively active form of IB kinase  (IKK), which the p22 form of Tal1 is expressed under the control of
the proximal promoter of the lck gene. Similar to Id1, theled to the development of thymocytes to the DP stage
in a RAG1-deficient background (Voll et al., 2000). transgenic expression of Tal1 inhibited T cell develop-
ment. Coexpression of Id1 with Tal1 led to a synergisticE2A (including the alternative splicing products E12
and E47) and HEB are the bHLH transcription factors suppression of thymocyte development, suggesting that
these inhibitory molecules were probably affecting simi-expressed in the thymus and have been shown to be
involved in early stages of T cell development (Bain et lar targets, most likely the bHLH proteins, E2A and HEB.
To further investigate the role of bHLH proteins inal., 1997; Barndt et al., 1999; Zhuang et al., 1996). Be-
cause of the functional redundancy of E2A and HEB thymocyte development, we crossed Id1 transgenic
mice with RAG1-deficient mice and found that Id1 ex-genes, mice deficient for either the E2A or HEB gene
exhibit only a partial block in thymocyte development. pression enabled the differentiation of DN cells to the
DP stage. Surprisingly, we found that the transcriptionE2A- or HEB-deficient mice have reduced numbers of
total thymocytes. In particular, the percentages of DP factor NF-B was strongly activated in thymocytes from
Id1 and Tal1 transgenic mice. Further activation of NF-cells are lower and the percentages of DN cells are
higher than in wild-type mice. The combined biological B in these mice resulted in more severe impairment of
T cell development while inhibition of NF-B alleviatedfunction of both E2A and HEB proteins could only be
elucidated by the examination of transgenic mice ex- the T cell deficiency. These data suggest that the role
of bHLH proteins in T cell development may be to controlpressing transinhibitors for both E2A and HEB proteins.
Thus, we generated transgenic mice expressing the HLH the threshold of stimulation through the pre-TCR and
TCR signaling pathways. Inhibition of their functioninhibitor, Id1, which forms heterodimers with both E2A
and HEB and inhibits the DNA binding activities of these leads to hyperactivation of the pre-TCR signaling path-
way and results in the differentiation of RAG1-deficientproteins (Kim et al., 1999). Additionally, Barndt et al.
(2000) created knockin mice bearing a dominant-nega- DN cells to the DP stage in the absence of pre-TCR.
However, the hyperactivation of these signaling path-tive mutation of the HEB gene, which encodes a mutant
HEB protein that fails to bind to DNA and also interferes ways also causes massive apoptosis of DP thymocytes
because it mimics signaling that leads to negative selec-with the activity of E2A proteins. Thymocyte develop-
ment was severely blocked in both types of mice, and tion. Therefore, the bHLH proteins play multiple roles in
different stages of thymocyte development.there was evidence of massive apoptosis in the Id1-
transgenic mice. Detection of rearranged TCR and
TCR genes in the apoptotic cells led to the conclusion Results
that they were derived from more mature thymocytes,
most likely DP cells. The ability of Id1 to induce apopto- Dose-Dependent Inhibition of T Cell
Development by Id1 and Tal1sis of developing thymocytes suggests that bHLH pro-
teins may function to ensure the survival of T cells as We previously found that T cell development in Id1 trans-
genic mice is severely impaired, and massive apoptosisthey differentiate, although the underlying mechanism
by which they regulate this process remains to be under- occurs in the thymus (Kim et al., 1999). Since Id1 acts
as a dominant, competitive inhibitor of E2A and HEBstood.
Another family of inhibitors of E2A and HEB proteins proteins in vitro, its effect on T cell development might
be expected to be dose dependent. Indeed, mice homo-are products of the Tal1 gene, also called SCL (Begley
et al., 1989; Chen et al., 1990). The Tal1 gene encodes zygous for the Id1 transgene exhibited more complete
inhibition of T cell development than heterozygoustwo polypeptides, p42 and p22, through differential us-
age of the translation initiation sites in its transcript transgenic mice (Figures 1B and 1C). Over 90% of thy-
mocytes in the homozygous mice belonged to the(Begley et al., 1991). Tal1 is normally not expressed in
T cells but is activated aberrantly in 70% of human CD44CD25 DN-I population. This population can be
further divided into two groups based on their expres-acute lymphoblastic leukemias (Bash et al., 1995; Brown
et al., 1990). Both forms of the Tal1 protein contain HLH sion of the CD24 marker (Kim et al., 1999). Increasing
the concentration of one of the E2A proteins, E47, neu-motifs that are capable of mediating dimerization with
E2A and HEB proteins (Hsu et al., 1991). Although these tralized the effect of Id1 and rescued T cell development
in the Id1 and E47 transheterozygous mice (Figures 1Bheterodimers of Tal1 with E2A or HEB can bind to DNA,
they are unable to activate transcription (Hsu et al., 1994; and 1C). The developmental profile and total cellularity
of the transheterozygous mice are similar to those ofPark and Sun, 1998). Except for the target bHLH pro-
teins, Id1 and Tal1 neither share any common interac- the wild-type mice.
mice are labeled as Id1tg/tg and Id1tg, respectively. Transheterozygous mice are designated by separating the names of the two transgenes
with an “X.” The percentages of cells in each quadrant are indicated and the numbers of total thymocytes are listed under each genotype.
(C) CD44 and CD25 staining of DN cells in the same mice as shown in (B).
(D) Forward and side scatter analysis of mice with the indicated genotypes. Viable thymocytes were counted with the same gate settings,
and the percentages in total thymocytes are shown next to the gate.
(E) TUNEL analysis of wild-type and Id1 transgenic mice. Frozen thymus sections were used for TUNEL labeling with fluorescein isothiocyanate
conjugated dUTP. After fluorescence microscopy, the same sections were stained with H&E and photographed using light microscopy with
the same magnification.
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We have now generated transgenic mice expressing from the DN-III stage to the DP stage, although the total
number of thymocytes in the thymus did not increaseTal1-p22, another inhibitor of the E2A and HEB proteins.
Like Id1, Tal1 has a high affinity for E2A and HEB pro- (Figure 2). This dramatic result suggests that inhibition
of bHLH proteins by Id1 allows developing thymocytesteins. However, Tal1 heterodimers are incapable of driv-
ing transcription because Tal1 lacks an activation do- to bypass a differentiation checkpoint at the DN-III to
DP transition, which normally requires signals from pre-main that is compatible with E2A (Park and Sun, 1998).
Two independent lines of Tal1 transgenic mice, Tal1- TCR complexes. Although the cells can differentiate to
the DP stage, the numbers of DP cells did not increase,p22-8 and -13, displayed phenotypes similar to Id1
transgenic mice, namely a dramatic reduction in total probably because Id1 expression only removed the
checkpoint for differentiation but could not mimic thethymic cellularity and an accumulation of DN cells along
with a concomitant loss of DP cells (Figures 1B and proliferative effect of pre-TCR stimulation, which results
in the expansion in the numbers of DP cells. Neverthe-1C). More interestingly, when Tal1 transgenic mice were
crossed with Id1 transgenic mice, a more severe impair- less, the data in this experiment suggest that bHLH
proteins play important roles during  selection in T cellment of T cell development was observed in the trans-
heterozygous IdtgXTal1-p22tg-13 animals (Figures 1B development, perhaps by providing a checkpoint to reg-
ulate the level of pre-TCR signaling.and 1C). This phenotype is similar to that seen in the
Id1 homozygous mice, suggesting that the Id1 and Tal1 The situation was quite different for homozygous Id1
transgenic mice on the RAG1-deficient background.proteins most likely act through a shared mechanism in
a dose-dependent manner. Since E2A and HEB are the These animals completely lacked DP cells, and most
thymocytes were at the DN-I stage (Figure 2). The devel-only known targets for Id1 and Tal1, it is reasonable to
assume that the effects of Id1 and Tal1 are mediated opmental profiles of these mice were similar to those
of Id1 homozygous or Id1/Tal1 transheterozygous micethrough inhibition of these bHLH proteins.
As shown in Figure 1D, massive apoptosis occurred shown in Figure 1. Thus, it appears that in the presence
of high levels of E2A/HEB inhibitors, thymocyte develop-in Id1 and Tal1 transgenic mice, as revealed by forward
and side scatter analysis. Percentages of viable cells ment may also be impaired earlier at the DN-I to DN-III
stages, suggesting that the function of bHLH proteinsranged from 39%–61% in Id1 and Tal1 transgenic mice.
Apoptosis in Id1 transgenic mice was further evaluated may be required at multiple stages during thymocyte
development. It is possible, however, that completeby TdT-mediated dUTP nick end-labeling analysis
(TUNEL) (Figure 1E). Id1 transgenic thymi were much abolishment of E2A and HEB function may directly lead
to enhanced cell death, thereby contributing to the in-smaller in size, with only a thin rim of cortex and a low
density of thymocytes compared to those from wild- creased loss of cells seen in the homozygous mice or
in the Id1 and Tal1 transheterozygous mice.type mice. However, numerous apoptotic cells labeled
with fluorescent dUTP were found throughout the trans-
genic thymus, whereas very few labeled cells were Downregulation of E2A/HEB Function
detected in the wild-type thymus. Together with our by CD3 Stimulation
previous observations of DNA fragmentation by gel elec- Since inhibition of E2A/HEB function by Id1 overexpres-
trophoresis and TCR gene rearrangement in the frag- sion allowed DN cells to differentiate to the DP stage
mented DNA (Kim et al., 1999), we conclude that devel- without functional pre-TCR complexes (Figure 2), E2A
oping T cells undergo an increased rate of apoptosis in and HEB may provide a checkpoint for pre-TCR signals.
Id1 and Tal1 transgenic mice. This apoptotic phenome- Therefore, it is possible that pre-TCR signals normally
non is consistent with a striking characteristic of the downregulate E2A/HEB function when DN cells differen-
developmental profiles of homozygous or heterozygous tiate to the DP stage. To test this hypothesis, we injected
Id1 and Tal1 transgenic mice, namely a dramatic loss RAG1-deficient mice with antibodies against CD3 to
of DP cells (Figure 1B). Because DP cells constitute mimic pre-TCR signaling and assayed the DNA binding
about 70% of wild-type thymocytes, depletion of this activities of E2A and HEB. As shown in Figure 3, E2A/
population could account for the dramatic reduction of HEB binding activities decreased dramatically 8 or 12
total thymic cellularity observed in these mice. Since hr after an intraperitoneal injection with 50 	g of the
we have previously shown that the apoptosing cells anti-CD3 antibody, 145-2C11, but recovered 7 days
have undergone TCR and/or  gene rearrangement, later. These data suggest that pre-TCR signaling can
we hypothesize that one of the causes for apoptosis of transiently reduce the activity of E2A and HEB proteins.
the DP cells may be that these DP cells receive exces-
sive stimulatory signals from the pre-TCR or TCR in Id1 Activation of NF-B by Id1 and Tal1
or Tal1 transgenic mice. To understand the molecular mechanisms by which E2A
and HEB might influence pre-TCR (and also the TCR)
signaling, we examined the function of nuclear effectorsInduction of RAG1-Deficient Cell Differentiation by Id1
To explore the possibility that Id1 overexpression or loss known to be downstream of pre-TCR signaling in Id1
transgenic mice. AP-1 DNA binding activities of the Fosof E2A/HEB function may impact pre-TCR signaling, we
crossed Id1 transgenic mice with RAG1-deficient mice. and Jun proteins are activated by pre-TCR stimulation
(Jacobs, 2000). However, amounts of AP-1 binding com-Due to the lack of functional TCR chains to form pre-
TCR complexes, T cell development is arrested at the plexes detected by electrophoretic mobility shift assays
(EMSA) increase only slightly in Id1 transgenic as com-DN-III stage in RAG1-deficient mice. Interestingly, mod-
erate levels of Id1 expression in heterozygous trans- pared to wild-type and RAG1-deficient thymocytes (Fig-
ure 4A). Amounts of nuclear extracts in the binding reac-genic mice forced differentiation of RAG1-deficient cells
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Figure 2. Id1 Expression Enables RAG1-Deficient Cells to Differentiate to the DP Stage
Total thymocytes from mice with the indicated genotypes were stained for CD4 and CD8. Cells gated as DN were further analyzed for CD44
and CD25 expression. Percentages of cells in each quadrant are indicated. Numbers of total thymocytes are listed under each genotype.
tions were normalized with Oct-1 binding activities. 4A). Activation of both MAPK and PKC pathways by
pre-TCR signals leads to the degradation of IB andConstitutive signaling through pre-TCR has recently
been shown to stimulate the DNA binding activities of nuclear translocation of NF-B complexes, which bind
to NF-B recognition sequences in the promoters of NF-NFAT complexes (Aifantis et al., 2001); however, NFAT
activities were not enhanced in Id1 transgenic mice (Fig- B-responsive genes (Karin and Ben Neriah, 2000). The
NF-B family of transcription factors consists of multipleure 4A).
In contrast, NF-B, which is also a downstream ef- members that share a rel-homology domain, including
p50, p52, relB, p65, and c-Rel (Ghosh et al., 1998). Thesefector of pre-TCR signaling, was dramatically activated
in Id1 transgenic mice as measured by EMSA (Figure proteins form homo- or heterodimers that bind to DNA.
However, only complexes containing relB, p65, and
c-Rel are transcriptionally active. Supershift analyses
with antibodies against p50, p65, and c-Rel revealed
that the enhanced DNA binding activity in thymocytes
from Id1 transgenic mice could primarily be attributed
to complexes containing c-Rel (Figure 4B).
Since Id1 homozygous transgenic mice have predom-
inantly DN-I cells in the thymus, it is conceivable that
the enhanced NF-B binding activity was intrinsic to
that subset of cells. To directly test this possibility, we
analyzed the NF-B activities in Id1 and Tal1 heterozy-
gous transgenic mice, which have sufficient numbers
of cells beyond the DN-I stage (Figures 1B and 1C). In
this experiment, nuclear extracts were prepared from
thymocytes of Id1 and Tal1 heterozygous mice, in which
DN-I cells comprised only 57% and 13% of total thymo-
Figure 3. Downregulation of E2A/HEB Binding Activities by Anti-
cytes, respectively. As shown in Figure 4C, NF-B activi-CD3 Treatment
ties in these heterozygous mice were elevated as in Id1EMSA was performed using nuclear extracts from RAG/ mice with
homozygous mice. This result therefore suggests thatno treatment or with anti-CD3 antibodies for 8 hr, 12 hr, or 7 days.
NF-B activation is likely to be the consequence of aTwo complexes specifically binding to the E box-containing probe
are probably mixtures of E2A/HEB homo- and heterodimers. They loss of E2A/HEB function rather than being intrinsic to
are thus labeled E2A/HEB. Nonspecific binding complexes are indi- the DN-I cells enriched in thymocytes of Id1 homozy-
cated as “NS.” Antibodies specific to E2A proteins (-E47) were gous transgenic mice. Moreover, it has been shown that
used for the supershift assay and may potentially react to HEB
the DN-I and DN-II cells do not have high levels of NF-proteins. Nonspecific control antibodies (C) for the supershift assay
B activity (Voll et al., 2000). Supershift experiments withwere directed against C/EBP-. Amounts of Oct-1 binding com-
plexes were used as a control. antibodies specific to c-Rel revealed that the majority
Immunity
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Figure 4. Activation of NF-B in Id1 and Tal1
Transgenic Mice
(A) EMSA using nuclear extract from wild-
type, RAG1/, and Id1tg/tg mice. DNA binding
complexes for each probe are indicated on
the left side of the gels. Amounts of Oct-1
binding complexes were used to estimate the
quantities and qualities of nuclear extracts
used for each binding reaction. EMSA with
nuclear extracts from 166D10 T cells cultured
with or without stimulation with PMA and Io-
nomycin (PI) were performed as positive
controls for AP-1 activities.
(B) Supershift of NF-B complexes in wild-
type and Id1tg/tg mice (marked with —-) with
antibodies specifically against different NF-
B proteins as indicated on the top of the
lanes.
(C) Comparison of NF-B DNA binding activi-
ties in different transgenic mice. EMSA and
supershift analyses with anti-c-rel antibodies
were performed with nuclear extracts from
mice with the indicated genotype. Oct-1 bind-
ing complexes served as controls.
(D) Expression of NF-B and IB proteins.
Western blots were performed using whole-
cell extracts from mice with the indicated ge-
notypes. Proteins specifically reacting to the
antibodies are indicated on the side of the
gels. Amounts of TFIIH protein were used as
a control for the amounts of proteins loaded
in each lane. RT-PCR assays were carried out
using cDNAs prepared from total RNA from
mice with the indicated genotype. PCR ampli-
fication was performed with primers specific
to each transcript as labeled and in two differ-
ent numbers of cycles as indicated. Amounts
of GAPDH product were used as an internal
control.
(E) IB phosphorylation. Western blots with
antibodies against IB with and without
phosphorylation (P-IB and IB) were per-
formed with whole-cell extracts from thymo-
cytes of the indicated genotypes. The amount
of proteins detected in each lane was quanti-
fied with a LuminImager. The amount of phos-
pho-IBwas normalized against that of total
IB, and the relative amount of phospho-IB in each sample is listed below the lane. Amounts of TFIIH served as an internal control for
the amount of protein loaded.
(F) Levels and activities of the IB kinase. Whole-cell extracts from indicated thymocytes were used in Western blots with antibodies against
IKK and TFIIH. For kinase assays, the extracts were immunoprecipitated with antibodies against NEMO (IKK), and the precipitates were
used in kinase assays as previously described (Voll et al., 2000). GST-IB was used as a substrate.
of NF-B complexes contained c-Rel. The presence of rise to p50) has previously been shown to be induced by
NF-B (Chiao et al., 1994; Lin et al., 1995), the increasedc-Rel normally suggests constitutive activation of NF-
B (Miyamoto et al., 1994), so inhibition of E2A/HEB steady-state levels of these proteins may have resulted
from increased gene expression mediated by active NF-function most likely leads to the prolonged activation of
NF-B activity in these thymocytes. B in these cells. Indeed, the levels of mRNAs encoding
these proteins, as well as IB which is also regulatedLevels of NF-B and IB proteins in the wild-type,
RAG1-deficient, Id1 and Tal1 transgenic mice were then by NF-B (Miyamoto et al., 1994), were significantly
higher in Id1 and Tal1 transgenic mice than in wild-compared using immunoblot analysis (Figure 4D).
Among the NF-B proteins, levels of p65 were similar, type or RAG1-deficient mice (Figure 4D). These results
suggest that constitutive activation of NF-B occurs inwhile those of c-Rel and p50 were greatly increased in
Id1 and Tal1 transgenic mice. Levels of IB, IB, and the transgenic mice, which in turn leads to increased
production of p50 and c-Rel proteins.IB remained relatively unchanged compared to wild-
type mice, probably reflecting their continuous degrada- To investigate the mechanism through which Rel/NF-
B proteins are activated in Id1-expressing thymocytes,tion and resynthesis. Taken together, these observa-
tions are consistent with our finding that NF-B activities we examined the status of phosphorylation of IB by
immunoblotting with antibodies against phospho-IB.are significantly enhanced in Id1 and Tal1 transgenic
mice. Since expression of c-Rel and p105 (which gives Interestingly, the amount of phospho-IB in thymo-
Activation of Rel/NF-B by bHLH Inhibitors
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Figure 5. Crosstalks between bHLH and NF-B Proteins in T Cell Development
(A) Synergistic effects of Id1 and IKK transgenes.
(B) Rescue of Id1 transgenic DP cells by inhibition of NF-B. Total thymocytes from littermates with the indicated genotypes were stained
for CD4 and CD8. The total number of thymocytes is listed under each genotype. Data shown are examples of at least five (for [A]) and ten
(for [B]) similar experiments.
cytes from Id1 homo- or heterozygous transgenic mice is expressed under the control of the lck proximal pro-
moter (Voll et al., 2000). Expression of this form of IKKwas significantly greater compared to wild-type mice
(Figure 5E), suggesting that NF-B activation in these in transgenic mice has been shown to facilitate the sur-
vival of DN-IV cells in the wild-type background and inthymocytes probably occurred through activation of the
IB kinase. To determine whether the classical IB ki- the progression of RAG1-deficient DN-III cells to the
DP stage. As shown in Figure 5A, heterozygous Id1nase complex was activated in these cells, we examined
the level of kinase activity in immunoprecipitates using transgenic mice in this litter had a higher percentage
of DP cells and slightly larger numbers of thymocytesantibodies against NEMO/IKK, the regulatory subunit
of IKK complexes (Karin and Ben Neriah, 2000). Although compared to those shown in Figure 1. This is probably
due to variations in the levels of Id1 transgene expres-the amount of IKK, the catalytic subunit mainly respon-
sible for inducible phosphorylation of IB, was elevated sion in a mixed genetic background. Transgenic mice
carrying the IKK allele exhibited a relatively normalslightly in Id1-expressing thymocytes, the IKK kinase
activity was markedly increased in the thymocytes from developmental profile. However, T cell development was
completely arrested in the Id1 and IKK transheterozy-Id1 transgenic mice compared to wild-type mice (Figure
4F). Therefore, these results suggest that Id1 expression gous littermate, a phenotype equivalent to that in Id1
homozygous mice or Id1 and Tal1 transheterozygousleads to activation of the classical NF-B signaling path-
way involving the IKK complex, resulting in the subse- mice (Figure 1). A similar observation was also obtained
by crossing Tal1 (p22tg-8) with IKK transgenic animalsquent phosphorylation of IB.
(data not shown). These results thus support the hypoth-
esis that the dramatic reduction in T cell numbers ob-Synergistic Effects on T Cell Development
through Activation of NF-B and Inhibition served in the Id1 and Tal1 transgenic mice may, at least
in part, be due to aberrant hyperactivation of NF-B.of E2A/HEB Function
If activation of NF-B in Id1 and Tal1 transgenic mice
contributes to the dramatic loss of T cells, it would be Inhibition of NF-B Partially Rescues DP
Cells in Id1 Transgenic Miceexpected that further activation of NF-B in these mice
would exacerbate the situation. To test this hypothesis, If activation of NF-B upon removal of E2A and HEB
contributes to a loss of DP cells, then inhibition of NF-Bwe crossed Id1 or Tal1 transgenic mice with IKK trans-
genic mice, in which a constitutively active form of IKK should facilitate the survival of DP cells in Id1 transgenic
Immunity
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Table 1. Summary of Key Phenotypes of Transgenic or Knockout Mice
Mice DN (%) DP (%) Total Number Data Source
WT 3.7 65 2 
 108 Figure 1
Id1tg 42 14 4 
 106 Figure 1
Id1tg/tg 93 1.4 3 
 106 Figure 1
p22tg-8 49 2.1 6 
 106 Figure 1
p22tg-13 48 11 6 
 106 Figure 1
RAG1/ 98 0.5 5 
 106 Figure 2
Id1tg 
 RAG1/ 30 58 5 
 106 Figure 2
1Id1tg 14 74 1.8 
 107 Figure 5
IKKtg 1.9 84 2.5 
 108 Figure 5
Id1tg 
 IKKtg 96 0.8 5 
 106 Figure 5
2Id1tg 55 7.7 4.5 
 106 Figure 5
IBtg 1.7 84 1 
 108 Figure 5
Id1tg 
 IBtg 15 65 1.5 
 107 Figure 5
1 A littermate of the Id xIKK transheterozygous mouse.
2 A littermate of the Id xIB transheterozygous mouse.
animals (Figure 5B). To test this hypothesis, Id1 trans- TCR signals by anti-CD3 treatment reduced bHLH activ-
ity. Additionally, we found that NF-B activity was aug-genic mice were crossed with transgenic mice express-
ing a superinhibitor of NF-B, an IB protein with muta- mented in thymocytes lacking bHLH function. Although
Rel/NF-B family proteins normally provide survival sig-tions that render the protein resistant to signal-mediated
degradation (Voll et al., 2000). Although heterozygous nals to maturing T lineage lymphocytes (Voll et al., 2000),
in the absence of bHLH function, the activation of NF-mutant IB transgenic mice displayed a relatively simi-
lar developmental profile to wild-type mice, Id1 and IB B exacerbated cell death while the inhibition of NF-B
rescued DP cells (Table 1). Collectively, these observa-transheterozygous mice had significantly higher per-
centages of DP cells as compared to Id1 transgenic tions indicate that HLH proteins serve as modulators
of pre-TCR and TCR signaling, in part by regulatingmice (65% versus 7.7%), accompanied by a reduction
in the percentage of DN cells. Furthermore, the total activities of NF-B proteins.
numbers of thymocytes in the transheterozygotes were
increased by at least 3-fold relative to the Id1 heterozy- The Role of E2A and HEB Proteins in Pre-TCR-
gotes. Therefore, these data suggest that inhibition of Mediated T Cell Development
NF-B by the superinhibitor IB can partly overcome T cell differentiation, expansion, and survival are largely
the death of DP cells. The partial rescue observed here dependent upon signals transmitted through pre-TCR
might be due to an insufficient amount of the superinhib- and TCR. In the absence of a functional pre-TCR, T cell
itor expressed in the heterozygous mice, as the superin- development is arrested at the DN-III stage, where a
hibitor has been shown to act in a dose-dependent man- developmental checkpoint exists. Our data suggest that
ner (Voll et al., 2000). Alternatively, hyperactivation of E2A/HEB proteins play an important role in modulating
NF-B may be only one of the factors involved in the this checkpoint by providing a block for the differentia-
apoptosis of DP cells in Id1 transgenic mice, and other tion of DN cells, which is normally overcome by signaling
defects cannot be corrected by the inhibition of NF-B. from the pre-TCR complexes. Therefore, overexpres-
Taken together, these results are compatible with the sion of the inhibitors Id1 and Tal1 probably mimics pre-
notion that the function of bHLH and NF-B families TCR signaling by reducing the activity of E2A/HEB pro-
of proteins must be closely modulated during T cell teins at the DN-III to DN-IV developmental transition
development, and cooperation between these mole- (Figure 6). As shown in this report, the lowering of E2A/
cules is critical for appropriate interpretation of signals HEB function also leads to the activation of some of
originating from pre-TCR and TCR. the nuclear effectors that are downstream of pre-TCR
signaling pathways such as NF-B.
If bHLH proteins such as E2A and HEB play an impor-Discussion
tant role in setting up a checkpoint for pre-TCR signal-
ing, then elimination of the function of these proteinsThis study revealed that two families of transcription
factors appear to cooperate to regulate critical steps in might be an integral step in normal pre-TCR-mediated
differentiation of DN cells. Indeed, signaling through theT lymphocyte differentiation. All functional bHLH activity
could be experimentally reduced in a dose-dependent pre-TCR pathway induced by anti-CD3 treatment tran-
siently decreased bHLH DNA binding activity in RAG1-manner with combinations of Id1 and Tal1 transgenes.
This led to a severe impairment of thymocyte develop- deficient mice. Interestingly, it has been shown that acti-
vation of the MAP kinase pathway in T cells, either byment in transgenic mice, which are characterized by
partial or complete loss of DP cells and a dramatic re- anti-CD3 treatment or by expression of the constitutively
active lck or Ras protein, enhances the expression ofduction in the total numbers of thymocytes (summarized
in Table 1). Inhibition of bHLH activity also allowed the the Id3 gene, a member of the Id class of bHLH inhibitors
(Bain et al., 2001). Therefore, it is not surprising thatprogression of thymocytes to the DP stage in the ab-
sence of pre-TCR signaling, whereas mimicking pre- E2A/HEB activities are inhibited after treatment with the
Activation of Rel/NF-B by bHLH Inhibitors
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Figure 6. Models of E2A and HEB Function
(Left) During normal T cell development, both the pre-TCR and TCR signals through similar pathways that lead to activation of NF-B
transcription factors as well as other transcription factors such as AP-1 and NF-AT. E2A and HEB may balance signals from pre-TCR or TCR
by negatively influencing the function of the downstream transcription factors. This could prevent overstimulation, ensuring proper differentiation
and proliferation.
(Center) Id1 expression inhibits E2A and HEB and thus removes the DN to DP transition checkpoint, allowing cells to differentiate in the
absence of pre-TCR signals in RAG1-deficient mice.
(Right) Once the cells reach the DP stage, inhibition of E2A and HEB by Id1 causes overstimulation of the cells by TCR engagement and
leads to consequent apoptosis.
anti-CD3 antibody. Furthermore, treatment of RAG1- The Role of E2A/HEB in TCR-Mediated
T Cell Developmentdeficient mice with the anti-CD3 antibody also leads
to the activation of NF-B in the DN-III cells (Voll et al., T cells that develop in the thymus have to first pass 
selection for pre-TCR function and then undergo both2000). These findings would suggest that inhibition of
E2A/HEB function by Id1 and Tal1 is accompanied by positive and negative selection before moving on to the
periphery. While the purpose of positive selection is tothe activation of NF-B (Figure 4).
It is important to note that other transcription factors, favor the expansion of cells carrying functional TCRs
with moderate affinities to self-peptide and self-MHCsuch as the Ikaros family of proteins, also play a role in
this checkpoint because disruption of the Ikaros gene complexes, the purpose of negative selection is to re-
move cells expressing TCR with high affinities to self-allows thymocytes to differentiate to the DP stage in
mice lacking RAG1 (Winandy et al., 1999). Also, similar peptide and self-MHC complexes (Nossal, 1994; von
Boehmer, 1994). Two hypotheses have been proposedto the effect reported in this paper, the forced differentia-
tion of thymocytes to the DP stage through removal to explain why signals from TCR engagement with MHC
complexes can result in dramatically different outcomesof Ikaros occurs without a significant expansion in the
numbers of thymocytes. Unlike E2A/HEB and Ikaros, during positive and negative selection: cell survival and
expansion or cell death. The differential signal hypothe-whose removal appears to push differentiation of thymo-
cytes to the DP stage in RAG1-deficient mice, overex- sis suggests that distinct signals are transmitted during
positive selection and negative selection and thereforepression of a constitutively active form of IKK leads
to the stimulation of endogenous NF-B activity in the the consequences of such signaling are different (Alber-
ola-Ila et al., 1996). The alternative avidity hypothesisthymus and also promotes the progression of RAG1-
deficient cells to the DP stage without increases in the states that the positive and negative outcomes of TCR
engagement with the MHC complexes depend on thenumbers of thymocytes (Voll et al., 2000). Expression of
the Egr-1 immediate-early gene, which is normally strength of the signals delivered by the receptors, which
is proportional to the affinities of the receptors to theturned on during  selection (Shao et al., 1997), enables
RAG2-deficient cells to differentiate to the immature MHC complexes and the numbers of the receptors on
the cells (Ashton-Rickardt et al., 1994).CD8 single-positive stage (Miyazaki, 1997). However, it
remains unclear how the loss or gain of function of these One of the most remarkable effects seen in the Id1
or Tal1 transgenic mice is the nearly complete depletiontranscription factors with distinct target genes can all
influence this same checkpoint in pre-TCR-mediated of DP cells. Since Id1 overexpression promotes the dif-
ferentiation of RAG1-deficient cells to the DP stage, wethymocyte development.
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would suggest that inhibition of E2A/HEB function by the survival of DN-III and DN-IV cells as they differenti-
ate, it could result in apoptosis at the DP stage through aId1 might have lowered pre-TCR signal thresholds re-
quired for cells to differentiate to the DP stage. Without pseudo-negative selection mechanism. This hypothesis
would be consistent with the depletion of DP cells inE2A/HEB function, cells can reach the DP stage without
pre-TCR signals. We suspect that the lack of E2A/HEB Id1 and Tal1 transgenic mice. Furthermore, expression
at a higher level of the constitutively active form of IKKfunction also reduces the threshold for TCR-mediated
stimulation at the DP stage. As a consequence, DP cells in the homozygous transgenic mice resulted in a dra-
matic activation of NF-B and also caused apoptosismight overreact to signals normally meant for positive
selection and trigger apoptosis through the mechanisms of the DP cells (E.J. and S.G., unpublished data). A third
explanation could be that differences in the componentsanalogous to those normally occurring during negative
selection, a process that we refer to as “pseudo-nega- of NF-B complexes in wild-type and Id1 or Tal1 trans-
genic mice may yield different outcomes in cellular re-tive selection” (Figure 6). This hypothesis is consistent
with our findings that DP cells are depleted in Id1 trans- sponse, possibly as a result of different target genes
being expressed. Although NF-B complexes normallygenic mice and the apoptotic cells appear to have under-
gone rearrangement in the TCR and/or  chain loci. activated during pre-TCR stimulation in wild-type mice
consisted predominantly of p50 and p65 subunits (Voll etTherefore, it appears that E2A and HEB help to deter-
mine the appropriate level of response to TCR-mediated al., 2000), complexes detected in Id1 and Tal1 transgenic
mice were highly enriched in c-Rel, which has beenstimulation.
Further support for this hypothesis comes from exami- shown to cause apoptosis when overexpressed in avian
embryos and bone marrow cells (Abbadie et al., 1993).nation of Id3-deficient mice (Rivera et al., 2000). The
lack of Id3 diminished class II-mediated positive selec- Finally, the inhibition of the E2A and HEB function by Id1
and Tal1 may have a broader effect than the activation oftion and impaired differentiation of CD4 SP cells when
tested by crossing Id3-deficient mice with the AND NF-B alone. Therefore, a combination of these effects
may lead to the massive apoptosis observed in thesetransgenic mice, which express a class II-restricted
TCR. Also, when the H-Y transgenes encoding class transgenic mice. In keeping with this idea, the Id1 and
Tal1 transgenic mice develop T cell lymphomas at aboutI-restricted TCR against a male-specific antigen were
introduced into Id3-deficient mice, class I-mediated 3 months of age (Kim et al., 1999), but IKK transgenic
mice do not have this phenotype, which would suggestpositive selection was somewhat impaired in female
mice, but negative selection was severely perturbed in that the loss of E2A/HEB function might influence other
cellular processes such as growth control.the male animals. Reciprocally, disruption of the E47
exon in the E2A gene caused a partial reduction in the How the loss of E2A/HEB function results in NF-B
activation is not understood and needs to be furtheractivities of bHLH proteins and an acceleration of both
class I- and II-mediated positive selection without any investigated. As shown in Figure 4F, we have found that
the IKK complex is activated in Id1-expressing thymo-effect on negative selection (Bain et al., 1999). These
results suggest that E2A proteins may normally have a cytes. Under normal circumstances in thymocytes, the
IKK complex is activated as a consequence of signalingnegative effect on TCR signaling and are inhibited by
regulated expression of the Id3 gene during positive and from the pre-TCR or the TCR by a pathway involving
protein kinase C  and MAP kinases. However, neithernegative selection. Failure to suppress E2A function at
appropriate stages by Id3 could impair both positive and the activity of PKC nor MAP kinases is significantly
increased in the Id1 transgenic thymocytes (data notnegative selection. However, constitutive and complete
inhibition of all bHLH activities, as seen in Id1 and Tal1 shown), suggesting that NF-B activation in these cells
is due to signaling through some other pathway. Inhibi-transgenic mice, would result in hyperstimulation and
consequent cell death due to pseudo-negative se- tion of E2A and HEB function by Id1 and Tal1 probably
leads to a reduction in the expression of target geneslection.
of E2A and HEB, and some of these genes could directly
or indirectly control NF-B activation by this alternateThe Relationship between E2A/HEB and NF-B
pathway. A better understanding of the mechanisms byOne of the most striking and surprising observations in
which NF-B is activated in Id1 and Tal1 transgenic micethis report was the dramatic increase in NF-B activity
will therefore be aided by a greater knowledge of E2Ain Id1 and Tal1 transgenic mice. Although the Rel/NF-
and HEB target genes.B transcription factors normally act as survival factors
In summary, the studies reported in this paper de-and have been shown to promote the survival of
scribe a novel role for E2A and HEB proteins in regulating-selected DN-IV cells (Voll et al., 2000), overactivation
thymocyte differentiation. These proteins appear toof NF-B in Id1 and Tal1 transgenic mice appears to
serve as modulators of pre-TCR and TCR signaling bylead to massive apoptosis. There could be several expla-
establishing thresholds for stimulation. In the presencenations for these results. First, the biological outcome,
of weak or no pre-TCR signals, E2A and HEB blockapoptosis or survival, may depend on the level of NF-B
further differentiation of the DN cells. In the presenceactivation. A moderate level of activation might facilitate
of strong signals, they prevent overstimulation, whichsurvival of thymocytes, as probably occurs during 
may cause apoptosis. E2A and HEB appear to carryselection. However, an extremely high level of activation
out these functions, at least in part, by modulating theof NF-B, as seen in Id1 and Tal1 transgenic mice, could
activities of NF-B proteins, which are important down-lead to cell death (Senftleben et al., 2001). Second, cells
stream effectors of both pre-TCR and TCR signalingat different developmental stages may react differently
to NF-B activation. While activation of NF-B promotes pathways.
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Experimental Procedures deoxycholate, and 0.1% SDS), and the supernatants were collected
after centrifugation. Protein concentrations were determined by us-
ing the BCA reagents (Pierce, Rockford, IL). Fifty micrograms ofMice
The Id1 transgenic mouse line was previously described as Id1-28 each protein extract was analyzed using SDS-polyacrylamide gels.
Antibodies against c-rel, p65, p50, IB, IB, and IB were pur-(Kim et al., 1999). Homozygous Id1 transgenic mice were generated
by intercrossing Id1-28 male and female mice. The Tal1 transgenic chased from Santa Cruz Biotechnologies (Santa Cruz, CA). Antibod-
ies against IKK- and phospho-IB were from Cell Signaling Tech-construct was generated by inserting human Tal1 cDNA encoding
the 22 kDa polypeptide into the BamHI site of the vector, plck-hGH nology (Beverly, MA).
(Garvin et al., 1990), which contains the T cell-specific proximal
promoter of the lck gene and the human growth hormone gene with Acknowledgments
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Flow Cytometry
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